Abstract
Objective
The objective was to determine the teratogenicity of dimenhydrinate, an anti-emetic drug.
Methods
We compared patients with congenital abnormalities with matched normal controls. Cases were taken from the population-based data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities between 1980 and 1996, while matched controls were from the National Birth Registry of the Central Statistical Office.
Results
Out of 38,151 newborn infants with no congenital abnormalities (control group), 1,726 (4.5%) were treated with dimenhydrinate during pregnancy, while out of 22,843 cases with congenital abnormalities, the number was 914 (4.0%; unadjusted prevalence odds ratio with 95% confidence interval: 0.9, 0.8–1.0). There was thus no indication of teratogenicity with dimenhydrinate. However, a lower rate of obstructive uropathy was found in infants born to mothers treated with dimenhydrinate during the first trimester of pregnancy than in infants whose mothers did not take the drug at that time.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Briggs GG, Freeman RK, Yaffe SJ (1998) Drugs in pregnancy and lactation, 5th edn. Williams and Wilkins, Baltimore
Czeizel AE (1997) The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 5:299–305
Czeizel AE, Rockenbauer M, Siffel CS, Varga E (2001) Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980–1996. Teratology 63:176–185
Czeizel AE, Petik D, Vargha P (2003) Validation studies of drug exposures in pregnant women. Pharmacoepidemiol Drug Saf 12:409–416
Friedman JM, Polifka JE (1996) The effects of drugs on the fetus and nursing infant. Johns Hopkins University, Baltimore
Gross S, Librach C, Cecutti A (1989) Maternal weight loss associated with hyperemesis gravidarum: a predictor of fetal outcomes. Am J Obstet Gynecol 160:906–909
Heinonen OP, Slone D, Shapiro S (1977) Birth defects and drugs in pregnancy. John Wright—PSG, Littleton
McColl JD, Globus M, Robruson S (1965) Effect of some therapeutic agents in the developing rat fetus. Toxicol Appl Pharmacol 7:409–417
Mellin GW, Katzenstein M (1963) Meclozine and fetal abnormalities. Lancet 1:222–223
Mitchelson F (1992) Pharmacological agents affecting emesis. A review. I. Drugs 43:295–315
Mitchelson F (1992) Pharmacological agents affecting emesis. A review. II. Drugs 43:443–463
Nelson MM, Forfar JO (1971) Association between drugs administered during pregnancy and congenital abnormalities of the fetus. Br J Med 1:523–527
Rockenbauer J, Olsen J, Czeizel AE et al (2001) Recall bias in a case-control study on the use of medicine during pregnancy. Epidemiology 12:461–466
Shepard TH (1998) Catalog of teratogenic agents, 9th edn. Johns Hopkins University, Baltimore
Weigel RM, Weigel MM (1989) Nausea and vomiting of early pregnancy and pregnancy outcome. A meta-analytical review. Br J Obstet Gynecol 96:1312–1318
Yoo GD, Axelson JE, Taylor SM, Rurak DW (1986) Placental transfer of diphenhydramine in chronically instrumented pregnant sheep. J Pharm Sci 75:685–687
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Czeizel, A.E., Vargha, P. A case-control study of congenital abnormality and dimenhydrinate usage during pregnancy. Arch Gynecol Obstet 271, 113–118 (2005). https://doi.org/10.1007/s00404-004-0638-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-004-0638-6